Walk-In Lab logo
  • 0
Logo

Porphyrins Urine Test, Quantitative, Random

Share copy the link
Link copied!
share on Twitter Share on Facebook Share on Pinterest

The porphyrins urine test is the initial test for porphyrias.

LabCorp

heart
Sample Report Compare
Test Code:

120980

CPT Code(s):

84120

Also Known As:

Coproporphyrin: Uroporphyrin

Methodology:

High-pressure liquid chromatography (HPLC) with fluorometric detection

Specimen:

Urine

Preparation:

No special preparation required.

Test Results:

3-5 days. May take longer based on weather, holiday or lab delays.

Details:

This test includes:

  • Coproporphyrin (CP) I
  • Coproporphyrin (CP) III
  • Heptacarboxylporphyrins (7-CP)
  • Hexacarboxylporphyrins (6-CP)
  • Pentacarboxylporphyrins (5-CP)
  • Uroporphyrins (UP) 

 

Walk-In Lab is prohibited from selling LabCorp tests to residents in the following states:NY, NJ, RI, MA, MD

Quest

heart
Sample Report Compare
Test Code:

36592

CPT Code(s):

84120

Methodology:

High Performance Liquid Chromatography (HPLC)

Specimen:

Urine

Preparation:

No special preparation required.

Test Results:

3-4 days. May take longer based on weather, holiday or lab delays.

Details:

This test includes:

  • Uroporphyrin I
  • Uroporphyrin III
  • Coproporphyrin I
  • Coproporphyrin III
  • Heptacarboxylporphyrins
  • Hexacarboxylporphyrins
  • Pentacarboxylporphyrins
  • Total Porphyrins 

Walk-In Lab is prohibited from selling Quest tests to residents in the following states:AZ, NY, NJ, RI


Excess urinary porphyrin excretion, or porphyrinuria, results from inhibition of key enzymatic steps in such clinical conditions as genetic deficiencies in heme production enzymes, hepatitis, renal disease, and erythroid disease, as well as by heavy metal inhibition of heme enzyme synthesis. In both experimental animals and in humans exposed to heavy metals, elevated levels of porphyrins have been found in urine. Studies have been conducted using urinary porphyrin measurements as heavy metal (eg, mercury) biomarkers in Autistic Spectrum Disorders (ASD). Greater than 50% of the ASD patients were found to have significant elevations of urinary coproporphyrin (CP) and pentacarboxylporphyrin (5-CP) of more than twofold to threefold above the mean of controls. Significant reductions in 5-CP and CP were observed in ASD patients following chelation therapy. The authors concluded that mercury exposure may play a causal role in a significant number of ASDs and that additional research needs to be conducted to further evaluate mercury toxicity in ASDs.

Search for a Lab Test, Home Kit or Discount Panel:

Today's Offers